200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 96684-39-8

96684-39-8

96684-39-8 | Piroxicam-β-cyclodextrincomplex

CAS No: 96684-39-8 Catalog No: AG01FOYK MDL No:

Product Description

Catalog Number:
AG01FOYK
Chemical Name:
Piroxicam-β-cyclodextrincomplex
CAS Number:
96684-39-8
IUPAC Name:
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol;4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1λ6,2-benzothiazine-3-carboxamide
InChI:
InChI=1S/C42H70O35.C15H13N3O4S/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51;1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h8-63H,1-7H2;2-9,19H,1H3,(H,16,17,20)/t8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-;/m1./s1
InChI Key:
LBPBSKKEZXLVBQ-ZQOBQRRWSA-N

Properties

Complexity:
2090  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
35  
Defined Bond Stereocenter Count:
0
Exact Mass:
1465.432g/mol
Formal Charge:
0
Heavy Atom Count:
100  
Hydrogen Bond Acceptor Count:
41  
Hydrogen Bond Donor Count:
23  
Isotope Atom Count:
0
Molecular Weight:
1466.333g/mol
Monoisotopic Mass:
1465.432g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
662A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Evaluation of piroxicam-beta-cyclodextrin as a preemptive analgesic in functional endoscopic sinus surgery. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100801
Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique. Journal of pharmaceutical sciences 20090201
Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain. Journal of clinical pharmacy and therapeutics 20081001
Impact of piroxicam beta-cyclodextrin on the efficacy of the intrauterine device in a rat model. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20070601
[Corneal edema and systemic NSAIDs]. Journal francais d'ophtalmologie 20070601
Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain. Bratislavske lekarske listy 20020101
Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC. Journal of pharmaceutical and biomedical analysis 20010901
Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin. International journal of clinical pharmacology and therapeutics 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.